IDYA
Price
$34.23
Change
+$7.44 (+27.77%)
Updated
Feb 3 closing price
Capitalization
3B
55 days until earnings call
Intraday BUY SELL Signals
IRON
Price
$79.71
Change
+$8.96 (+12.66%)
Updated
Feb 3 closing price
Capitalization
3.01B
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IDYA vs IRON

Header iconIDYA vs IRON Comparison
Open Charts IDYA vs IRONBanner chart's image
IDEAYA Biosciences
Price$34.23
Change+$7.44 (+27.77%)
Volume$639.01K
Capitalization3B
Disc Medicine
Price$79.71
Change+$8.96 (+12.66%)
Volume$242.04K
Capitalization3.01B
IDYA vs IRON Comparison Chart in %
IDYA
Daily Signal:
Gain/Loss:
IRON
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IDYA vs. IRON commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and IRON is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (IDYA: $34.23 vs. IRON: $79.71)
Brand notoriety: IDYA and IRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 69% vs. IRON: 42%
Market capitalization -- IDYA: $3B vs. IRON: $3.01B
IDYA [@Biotechnology] is valued at $3B. IRON’s [@Biotechnology] market capitalization is $3.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 1 FA rating(s) are green whileIRON’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 1 green, 4 red.
  • IRON’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than IRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 3 TA indicator(s) are bullish while IRON’s TA Score has 5 bullish TA indicator(s).

  • IDYA’s TA Score: 3 bullish, 6 bearish.
  • IRON’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IRON is a better buy in the short-term than IDYA.

Price Growth

IDYA (@Biotechnology) experienced а -1.47% price change this week, while IRON (@Biotechnology) price change was -2.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

Reported Earning Dates

IDYA is expected to report earnings on Mar 31, 2026.

IRON is expected to report earnings on Mar 27, 2026.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($3.01B) and IDYA($3B) have the same market capitalization . IRON YTD gains are higher at: 0.378 vs. IDYA (-0.984). IRON has higher annual earnings (EBITDA): -177.16M vs. IDYA (-204.84M). IDYA has more cash in the bank: 787M vs. IRON (616M). IDYA has less debt than IRON: IDYA (27.2M) vs IRON (31M). IDYA has higher revenues than IRON: IDYA (215M) vs IRON (0).
IDYAIRONIDYA / IRON
Capitalization3B3.01B100%
EBITDA-204.84M-177.16M116%
Gain YTD-0.9840.378-260%
P/E RatioN/AN/A-
Revenue215M0-
Total Cash787M616M128%
Total Debt27.2M31M88%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
63
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAIRON
RSI
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
75%
Bearish Trend 6 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signal:
Gain/Loss:
IRON
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MINIX50.220.08
+0.16%
MFS International Intrinsic Value I
PNVAX45.84-0.08
-0.17%
Putnam International Small Cap A
RSINX17.09-0.04
-0.23%
Victory RS Investors A
WSGAX12.17-0.05
-0.41%
Nomura Small Cap Growth A
JSEPX33.26-0.20
-0.60%
JPMorgan Small Cap Equity R3

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with NUVL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+0.50%
NUVL - IDYA
59%
Loosely correlated
+2.12%
OCUL - IDYA
57%
Loosely correlated
-6.99%
XENE - IDYA
56%
Loosely correlated
+1.62%
XNCR - IDYA
55%
Loosely correlated
-0.99%
BEAM - IDYA
54%
Loosely correlated
-0.11%
More

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with SYRE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
-1.17%
SYRE - IRON
54%
Loosely correlated
+1.65%
NCEL - IRON
54%
Loosely correlated
-0.73%
XNCR - IRON
52%
Loosely correlated
-0.99%
CGON - IRON
51%
Loosely correlated
-3.28%
IDYA - IRON
51%
Loosely correlated
+0.50%
More